U.S. Dialysis Services Market - Focused Insights 2024-2029

The U.S. dialysis services market is expected to grow at a CAGR of 1.29% from 2023 to 2029.

MARKET TRENDS & DRIVERS

Increasing Mobile Dialysis Service

The shift toward mobile and ambulatory care has increased significantly in recent years due to the increasing burden on healthcare services. Nowadays, dialysis services are available outside their homes. Mobile dialysis providers are rapidly increasing in developed countries. Increasing expenditure for dialysis services and the availability of mobile dialysis services show significant market growth opportunities. Mobile dialysis service providers give cost-effective solutions to patients as dialysis facilities. In the US, Odulair LLC is a well-known mobile dialysis service provider organization that delivers several dialysis services annually in the U.S. It is a mobile medical manufacturer pioneer in building commercial mobile dialysis units in the U.S. and international markets. Mobile dialysis facilities are available in three forms: mobile dialysis clinic, mobile dialysis unit, and mobile dialysis facility. These services provide short-term dialysis, hemodialysis, and peritoneal dialysis facilities. It is one of the cost-effective services available at off-site locations. It allows dialysis and other required solutions to be brought to care homes, low-income communities, and other healthcare services. Increasing kidney care facilities and a significantly rising patient population drive the high demand for these services. Moreover, mobile dialysis services are used in a state or federal disaster response.

Increasing Government Initiatives for Kidney Health

The growing concern related to kidney health has made the government and associated health authorities take one step forward to deliver a healthy life to people. In developed and developing countries, the increasing prevalence of chronic kidney disorders and end-stage kidney disorders significantly drives the demand for kidney care. Various government initiatives, such as patient-led and patient-centered advocacy, are included to improve kidney health by transforming patient dialysis outcomes. In 2012, the American Society of Nephrology (ASN) and the US FDA established the Kidney Health Initiative (KHI) as one of the major organizations where the kidney communities can work collaboratively to understand the challenges in drug development, innovations, devices, biologics, and food products to improve the kidney health for those who have kidney conditions. It is one of the largest consortiums in the Kidney Community. In 2015, the Kidney Health Initiatives Project, which supported dialysis innovations, delivered lucrative market growth opportunities since its incorporation. Since 2015, the Kidney Health Initiative Patient & Family Partnership Council (PFPC) has been helping KHI stakeholders network and encourage kidney patients and patient organizations. In addition, PFPC advises industry and research institute partners on patients' needs and preferences as innovative products are developed and planned. In 2020, the collaborative initiation between the Centre for Disease Control and Prevention and ASN aimed at identifying a complication inherent to contemporary dialysis infection. So, increasing government initiatives for kidney health positively impacts dialysis services and pushes for market growth.

Increasing Mergers & Acquisitions in Dialysis Service Sector

Several mergers and acquisitions have happened in the dialysis service industry in recent years. The most prominent market players acquired several small and mid-sized dialysis service providers for the business expansion. After the COVID-19 pandemic, significant changes happened in the market through mergers and acquisitions. The dialysis service market has become increasingly concentrated through mergers and acquisitions. Currently, dialysis services are provided by multinational and well-established firms. The world's leading company, Fresenius Medical Care, entered into a significant acquisition in 2022. To create a premier value-based kidney care provider in the global market, the company took a major step in executing its growth strategy for 2025. This major step will accelerate the transition to home dialysis services. Under this, the company decided to create a new company that combines the strength of 3 value-based care specialists. The company entered into a new agreement to develop an independent new company. This will unite Fresenius health partners, such as Fresenius Medical Care, with the U.S. Cricket Health leading patient engagement data platform and InterWell Health. This merger will help bring together the company's health partners with kidney care expertise. InterWell Health company has a strong network of 1,600 nephrologists. The new company will be combined with Fresenius Medical Care unit due to the majority owner and operating under InterWELL Health.

MARKET RESTRAINTS

Complications Associated with Dialysis Services

In dialysis services, certain factors, such as the body's biological activities and some external factors, act as barriers that hamper the adoption of dialysis services. Dialysis volume, flow, composition, and dwell time are related to hemodialysis and peritoneal dialysis. Moreover, patients carry some challenges and complications for the dialysis services, such as a significant symptom burden, dietary intake and adherence to fluid, constraints to dialysis sessions, and a considerable pill burden, which hampers the market growth. In hemodialysis and peritoneal dialysis services, some common and different challenges stand as a restraint and negatively impact the market growth.

SEGMENT ANALYSIS

INSIGHT BY SERVICE TYPE

The U.S. dialysis services market by service type is segmented into hemodialysis and peritoneal dialysis. The hemodialysis segment dominates with the largest market share in 2023. The dominance of this segment is attributed to the larger acceptance of hemodialysis and the presence of many dialysis centers that offer these services. In addition, factors such as the rising prevalence of diabetes and hypertension and the shortage of kidneys for transplantation in the U.S. are likely to augment market growth.

INSIGHT BY END-USER TYPE

The U.S. dialysis services market by end-user type is categorized into in-center dialysis, home dialysis, and hospital dialysis. The home dialysis segment shows significant growth, with the highest growth during the forecast period. Several factors positively impact the shift toward home dialysis. In the U.S., the trend toward home dialysis has grown significantly in recent years. Popular Medicare and public-to-private insurance policies offered by the government or individuals provide plenty of opportunities for market growth. One of the major factors that significantly drove the high market growth in the home healthcare setting was the COVID-19 pandemic, and several government and private entities came forward to deliver dialysis services at the patient's home.

INSIGHT BY DISEASE TYPE

The chronic kidney segment by disease type shows major growth, with the fastest-growing CAGR during the forecast period. The rising prevalence of chronic kidney diseases, increasing initiatives for kidney health improvement, and dialysis access for prevalent CKD patients contribute to market growth. By 2040, it is estimated that CKD will be among the top five leading causes of death. It shows the significant opportunities for market growth in the future. Moreover, during the COVID-19 pandemic, both chronic kidney disease (CKD) and end-stage kidney disease (ESKD) conditions significantly increased, which will deliver plenty of opportunities for dialysis services.

INSIGHT BY AGE GROUP TYPE

The above-60 age group segment dominated with the largest U.S. dialysis services market share in 2023. The increasing elderly/geriatric population with various kidney disorders is one of the major factors driving the market growth. Globally, the increasing geriatric population is driving up the high cost of dialysis services. Several factors are positively influencing the adoption of dialysis services, such as the higher prevalence of chronic kidney disease (CKD), end-stage kidney disease (ESKD), acute kidney injury (AKI), and rising infections of various viral and chronic diseases.

COMPETITIVE LANDSCAPE

The U.S. dialysis services market report consists of exclusive data on 28 vendors. The U.S. dialysis service market is highly competitive due to domestic, regional, and international players. Moreover, key market players' geographical presence and broad distribution channels increase market competitiveness through their primary dialysis service delivery strategies. The outbreak of the COVID-19 pandemic significantly increased the demand for home dialysis services, driving high competitiveness among market players and shifting them to look for various options to deliver the services during the pandemic. B. Braun Melsungen, DaVita, Baxter Renal Care Services, Dialysis Clinic (DCI), Fresenius Medical Care, NephroPlus, and Innovative Renal Care are market players in the dialysis service market.

VENDORS LIST

Key Vendors

• B. Braun Melsungen
• Baxter Renal Care Services
• Davita
• Dialysis Clinic Inc
• Fresenius Medical Care
• Innovative Renal Care
• NephroPlus

Other Prominent Vendors

• ARC Dialysis
• Atlantic Dialysis Management Services
• Centers for Dialysis Care
• Dialife
• Northwest Kidney Centers
• Rogosin Institutes
• Premier Dialysis
• Satellite Healthcare
• Sanderling Healthcare
• Terumo
• US Renal Care
• Concerto Renal Services
• American Dialysis Centers
• Mayo Clinic
• Quik Travel Staffing
• Hattiesburg Clinic
• Allmed Medical Care

KEY QUESTIONS ANSWERED:

1. What is the growth rate of the U.S. dialysis services market?

2. What are the key drivers of the U.S. dialysis services market?

3. How big is the U.S. dialysis services market?

4. Who are the major players in the U.S. dialysis services market?